ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

Nancy Davidson Named Director Of UPCI, Succeeding Herberman.

November 21, 2008

NCCN Updates Myeloma Clinical Practice Guidelines

September 26, 2003

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

FY’78 Construction Requests $44 Million, Budget At $12 Million

December 2, 1977

Congressional News: Senate To NIH: Administrative Offices Should Consolidate

September 20, 1996

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

November 26, 2010